Industry Experts

Laura von Schantz is Senior Director, Antibody Discovery at Lundbeck, with extensive experience in antibody engineering, biologics discovery and drug development. Previously, she served as Chief Technology Officer at Alligator Bioscience, where she oversaw technical development across preclinical and clinical antibody programs. She was instrumental in building antibody engineering capabilities for generating functional, developable drug candidates at optimal timelines and with reduced developmental risks. Laura holds a PhD in Immuno-technology and an executive MBA from Lund University, with a specialization in AI.